Chemomab Therapeutics (CMMB) Change in Receivables (2018 - 2019)
Chemomab Therapeutics (CMMB) posted Change in Receivables of -$3.8 million for Q4 2019, down 977.49% on a QoQ basis from -$351000.0 in Q3 2019, and down 163.99% year-over-year from $5.9 million in Q4 2018.
Chemomab Therapeutics (CMMB) Change in Receivables (2018 - 2019) Analysis & Trends
Chemomab Therapeutics' Change in Receivables history runs 2 years deep, the most recent figure standing at -$3.8 million for Q4 2019.
- Quarterly Change in Receivables fell 163.99% year-over-year to -$3.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was -$724000.0 (changed N/A YoY) and the FY2019 annual result came in at -$2.3 million, down 165.93% from the prior year.
- Change in Receivables was -$3.8 million for Q4 2019 at Chemomab Therapeutics, down from -$351000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $5.9 million in Q4 2018 and bottomed at -$3.8 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Chemomab Therapeutics | 704.11 Mn | 693.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -3.78 Mn |
| Dec 31, 2019 | -3.78 Mn |
| Sep 30, 2019 | -351,000.00 |
| Sep 30, 2019 | -351,000.00 |
| Dec 31, 2018 | 5.91 Mn |
| Dec 31, 2018 | 5.91 Mn |
| Sep 30, 2018 | -2.50 Mn |
| Sep 30, 2018 | -2.50 Mn |